Clifford Swan Investment Counsel LLC Novartis Ag Transaction History

Clifford Swan Investment Counsel LLC

  • $2.78 Billion
  • Q3 2024

A detailed history of Clifford Swan Investment Counsel LLC transactions in Novartis Ag stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 82,041 shares of NVS stock, worth $8.08 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
82,041
Previous 87,987 6.76%
Holding current value
$8.08 Million
Previous $9.37 Million 0.74%
% of portfolio
0.34%
Previous 0.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $631,048 - $718,811
-5,946 Reduced 6.76%
82,041 $9.44 Million
Q2 2024

Aug 06, 2024
SELL
$92.57 - $107.37 $38,416 - $44,558
-415 Reduced 0.47%
87,987 $9.37 Million
Q1 2024

Apr 16, 2024
SELL
$95.27 - $108.47 $367,742 - $418,694
-3,860 Reduced 4.18%
88,402 $8.55 Million
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $443,080 - $487,595
-4,802 Reduced 4.95%
92,262 $9.32 Million
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $68,584 - $76,114
-724 Reduced 0.74%
97,064 $9.89 Million
Q2 2023

Aug 03, 2023
SELL
$92.52 - $104.91 $28,126 - $31,892
-304 Reduced 0.31%
97,788 $9.87 Million
Q1 2023

May 05, 2023
SELL
$80.03 - $92.81 $302,433 - $350,728
-3,779 Reduced 3.71%
98,092 $9.02 Million
Q4 2022

Feb 02, 2023
SELL
$75.55 - $92.52 $133,496 - $163,482
-1,767 Reduced 1.7%
101,871 $9.24 Million
Q3 2022

Nov 04, 2022
SELL
$74.61 - $87.26 $362,753 - $424,258
-4,862 Reduced 4.48%
103,638 $7.88 Million
Q2 2022

Aug 04, 2022
SELL
$80.52 - $93.75 $29,792 - $34,687
-370 Reduced 0.34%
108,500 $9.17 Million
Q1 2022

May 03, 2022
SELL
$80.11 - $90.62 $213,413 - $241,411
-2,664 Reduced 2.39%
108,870 $9.55 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $29,807 - $32,960
-374 Reduced 0.33%
111,534 $9.76 Million
Q3 2021

Nov 02, 2021
SELL
$81.78 - $95.14 $124,959 - $145,373
-1,528 Reduced 1.35%
111,908 $9.15 Million
Q2 2021

Aug 05, 2021
BUY
$85.24 - $94.15 $520,475 - $574,879
6,106 Added 5.69%
113,436 $10.4 Million
Q1 2021

May 07, 2021
BUY
$83.5 - $98.47 $127,504 - $150,363
1,527 Added 1.44%
107,330 $9.18 Million
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $325,317 - $393,489
4,167 Added 4.1%
105,803 $9.99 Million
Q3 2020

Oct 30, 2020
SELL
$82.14 - $91.0 $115,324 - $127,764
-1,404 Reduced 1.36%
101,636 $8.84 Million
Q2 2020

Aug 06, 2020
SELL
$80.93 - $91.1 $166,230 - $187,119
-2,054 Reduced 1.95%
103,040 $9 Million
Q1 2020

Apr 09, 2020
SELL
$70.67 - $99.01 $181,551 - $254,356
-2,569 Reduced 2.39%
105,094 $8.67 Million
Q4 2019

Jan 30, 2020
SELL
$84.35 - $95.37 $652,784 - $738,068
-7,739 Reduced 6.71%
107,663 $10.2 Million
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $1.23 Million - $1.35 Million
-14,339 Reduced 11.05%
115,402 $10 Million
Q2 2019

Aug 13, 2019
SELL
$75.4 - $92.8 $77,285 - $95,120
-1,025 Reduced 0.78%
129,741 $11.8 Million
Q1 2019

May 14, 2019
SELL
$75.32 - $86.15 $158,096 - $180,828
-2,099 Reduced 1.58%
130,766 $12.6 Million
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $47,289 - $52,656
-642 Reduced 0.48%
132,865 $11.4 Million
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $223,579 - $258,616
3,340 Added 2.57%
133,507 $11.5 Million
Q2 2018

Aug 13, 2018
SELL
$64.91 - $73.36 $9,411 - $10,637
-145 Reduced 0.11%
130,167 $9.83 Million
Q1 2018

May 09, 2018
SELL
$70.39 - $84.15 $59,831 - $71,527
-850 Reduced 0.65%
130,312 $10.5 Million
Q4 2017

Feb 09, 2018
BUY
$72.33 - $77.64 $164,333 - $176,398
2,272 Added 1.76%
131,162 $11 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $249,851 - $260,399
3,370 Added 2.68%
128,890 $11.1 Million
Q2 2017

Aug 11, 2017
BUY
N/A
125,520
125,520 $10.5 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email